¿ÆÑм°½Ìѧ¿ÎÌâ
(1) leyuÀÖÓÚ¡°Ë«Ò»Á÷¡±Óë¸ßˮƽ´óѧѧ¿ÆÐͬ´´ÐÂÍŶÓÅàÓýÏîÄ¿£¬IBD´ó³¦ÊªÈÈÖ¤±¾Öʼ°ÆäÖÐÒ©¸ÉÔ¤£¬2021xk81£¬2021/01- 2023/12£¬20Íò£¬ÔÚÑУ¬Ö÷³Ö
(2)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬´ó»Æĵµ¤ÌÀ¼°Æä×é·Öͨ¹ýTL1A-ILC3ÐÞ¸´³¦ð¤Ä¤ËðÉËÖÎÁÆIBDµÄʵÑéleyuÀÖÓÚ£¬82074092£¬2021/01- 2024/12£¬55Íò£¬ÔÚÑУ¬Ö÷³Ö
(3)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬»ùÓÚTL1A/DR3Öá̽ÌÖ´ó»Æĵµ¤ÌÀµ÷¿Ø3Ð͹ÌÓÐÁÜ°Íϸ°ûÖÎÁÆIBDµÄ»úÖÆ£¨Òѹ«Ê¾£©£¬ÔÚÑУ¬Ö÷³Ö
(4)¹ã¶«Ê¡ÆÕͨ¸ßУÌØÉ«´´ÐÂÏîÄ¿£¬»ÆÜËËØͨ¹ý¼¤»îILC3-AHR/IL-22ͨ·ÐÞ¸´³¦ÉÏƤÖÎÁÆÀ£ÑñÐԽ᳦Ñ×£¬2020/06-2022/06£¬10Íò£¬ÔÚÑУ¬²ÎÓë
(5)leyuÀÖÓÚÇàÄêÓ¢²ÅÏîÄ¿£¬°ÐÏò·¼ÏãÌþÊÜÌ弤»îIL-22/STAT3ÐźÅͨ·ÔÚÇåÈÈÖ¹Á¡¸´·½ÐÞ¸´³¦ÉÏƤÖÎÁƳ¦Ñ×ÖеÄ×÷Óã¬ONYC20190104£¬2019/11-2023/11£¬20Íò£¬ÔÚÑУ¬²ÎÓë
(6)¹ã¶«Ê¡ÆÕͨ¸ßУÌØÉ«´´ÐÂÏîÄ¿£¬2017KTSCX042, ´ó»ÆËؼ¤»î PPAR¦ÃÐźŲúÉúÈýÖØЧӦ·¢»ÓÖÎÁÆIBDµÄ×÷Óã¬2018.01-2019.12£¬10ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(7)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄêÏîÄ¿£¬81703785£¬»ÆÜËÌÀÐÞ¸´Î¢ÉúÎïÆÁÕϼ°ÒÖÖÆMDP-NOD2Ñ×Ö¢ÐźÅͨ·ÖÎÁÆÑ×Ö¢ÐÔ³¦²¡£¬2018/01-2020/12£¬20ÍòÔª£¬ÒѽáÌ⣬²Î¼Ó
(8)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬2017A030313657£¬´Ó¶ÌÁ´Ö¬·¾ËáÒÖÖÆ¡°±Þëµ°°×-TLR5Ñ×Ö¢ÐźÅͨ·¡±Ì½ÌÖ´ó»Æĵµ¤ÌÀÖÎÁÆIBDµÄ»úÖÆ£¬2017/05-2020/05£¬10ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(9)2017¡°¸ßˮƽ´óѧ½¨É衱¹«¿ªÕбêÏîÄ¿£¬»ùÓÚ³¦µÀ¾úȺÓëÖÐÒ©½»»¥×÷ÓÃ̽ÌÖÄÏҩҩЧ×÷ÓûúÖÆ£¬2017/04-2018/06£¬20ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(10)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬81673668£¬´ó»Æĵµ¤ÌÀͨ¹ý¶ÌÁ´Ö¬·¾ËáÒÖÖÆ¡°±Þëµ°°×-TLR5Ñ×Ö¢ÐźÅͨ·¡±ÖÎÁÆIBDµÄ»úÖÆleyuÀÖÓÚ£¬2017/01-2020/12£¬60ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(11)2016ÄêУ´´Ð¿ÆÑÐÍŶÓÅàÓýÏîÄ¿£¬2016KYTD09£¬»ùÓÚÌåÄÚÍâÎïÖÊ×é¹ØÁªÍøÂç·ÖÎöµÄÐÄѪ¹Ü»îÐÔÄÏҩҩЧÎïÖÊ»ù´¡¼°×÷ÓûúÖÆleyuÀÖÓÚ£¬2016/07-2019/12£¬70ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(12)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬2015A030313344£¬´Ó³¦µÀ¾úȺµ÷¿ØTh17/Treg̽ÌÖ´ó»Æĵµ¤ÌÀÖÎÁÆIBDµÄ»úÖÆ£¬2015/08-2018/08£¬10ÍòÔª£¬ÒѽáÌ⣬²Î¼Ó
(13)¹ã¶«Ê¡¿Æ¼¼Ìü£¬2014B030301049£¬¹ã¶«Ê¡ÐÂҩɸѡÖصãʵÑéÊÒ£¬2014/09-2017/09£¬150ÍòÔª£¬ÒѽáÌ⣬¹²Í¬Ö÷³Ö
(14)¹ã¶«Ê¡Ê¡¼¶¿Æ¼¼¼Æ»®ÏîÄ¿£¬2013B090800052£¬ÕäÏ¡ÄÏÒ©¼ø¶¨²úѧÑкÏ×÷¿Æ¼¼´´ÐÂƽ̨£¬2014/12-2017/11£¬50ÍòÔª£¬ÒѽáÌ⣬¹²Í¬Ö÷³Ö
(15)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬81373697£¬Ð¡ÇàÁúÌÀͨPKC¦Ä/ERK/PARP-ÐźÅͨ·µ÷½ÚH1R±í´ïÖÎÁƱäÓ¦ÐÔ±ÇÑ׵ĻúÖÆleyuÀÖÓÚ£¬2014/01-2017/12£¬75ÍòÔª£¬ÒѽáÌ⣬²Î¼Ó
(16)ÓÅÐãÇàÄê¿ÆÑлù½ð£¬Ëľý×ÓÌÀ¶àÌǶԿ¹ÉúËØÒýÆðСÊó¾úȺʧµ÷¼°ÃâÒßËðÉ˵ı£»¤»úÖÆleyuÀÖÓÚ£¬2013/05-2016/05£¬5ÍòÔª£¬ÒѽáÌ⣬²Î¼Ó
(17)½ÌÓý²¿¸ßµÈѧУ²©Ê¿Ñ§¿ÆµãרÏî¿ÆÑлù½ð£¬20124425110010£¬»ùÓÚÁÜ°Íϸ°û¹é³²leyuÀÖÓÚÜòÜ߶àÌǶԳ¦Õ³Ä¤ÃâÒߵļ¤»î×÷Óã¬2013/01-2015/12£¬12ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(18)¹ã¶«Ê¡½ÌÓý²¿²úѧÑнáºÏ£¬2010A090200041£¬ÖÐÒ©»îÐÔ¶àÌÇ¿ìËÙɸѡƽ̨½¨Á¢¼°Æ佡¿µ²úÆ·²úÒµ»¯leyuÀÖÓÚ£¬2010/01-2012/12£¬150ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(19)½ÌÓý²¿²©Ê¿Ñ§¿ÆµãרÏî¿ÆÑлù½ð£¬200805720001£¬Í¨¹ýÖÐÒ©¶àÌǶԳ¦µÀճĤÃâÒßµÄÓ°Ïì̽ÌÖÖÐÒ©µÄ×÷Óã¬2009/01-2011/12£¬6ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(20)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬8151040701000022£¬Í¨¹ýÖÐÒ©¶àÌǶÔճĤÃâÒßµÄÓ°Ïì̽ÌÖÆäÃâÒßÒ©Àí»úÖÆ£¬2009/01-2011/12£¬5ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(21)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬30873415£¬Í¨¹ýÖÐÒ©¶àÌǶԳ¦µÀճĤÃâÒßµÄÓ°Ïì̽ÌÖÆä×÷ÓûúÖÆ£¬2009/01-2011/12£¬30ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(22)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬30772737£¬×ª¿¹¾úëÄ»ùÒòÑô´ºÉ°ÈʵÄʵÖʵÈͬÐÔÆÀ¼ÛleyuÀÖÓÚ£¬2008-2010£¬32ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(23)½ÌÓý²¿¸ßµÈѧУ²©Ê¿Ñ§¿ÆµãרÏî¿ÆÑлù½ð£¬20060572009£¬ÍâÔ´¿¹¾úëÄÔÚÑô´ºÉ°ÈÊÖеıí´ïÓëÆÀ¼ÛleyuÀÖÓÚ£¬2007-2009£¬6ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(24)¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö£¬060076£¬»ÆÁ¬½â¶¾ÌÀ¿¹Ñ×»úÀíµÄµ°°×Ö¸ÎÆͼÆ×ÕûÌå·ÖÎö£¬2006/10-2008/10£¬1ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(25)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð×ÔÓÉÉêÇëÏîÄ¿£¬5004272£¬¿¹¾úëÄ»ùÒòת»¯Ñô´ºÉ°Èʽ¨Á¢ÖÐÒ©ÐÂÆ·ÖÖµÄleyuÀÖÓÚ£¬2006/1-2007/12£¬6ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(26)¹ã¶«Ê¡¿Æ¼¼ÌüÐÇ»ð¼Æ»®ÏîÄ¿£¬2005EA780019£¬¹ã¶«É½ÇøÏØ÷ÏؽðèÖÒ©ÓüÛÖµµÄÀûÓÃÓ뿪·¢£¬2005/1-2007/12£¬ÒѽáÌ⣬²ÎÓë
(27)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬04300450£¬ÖÐÒ©Ñô´ºÉ°ÈʵÄת¿¹¾úëÄ»ùÒòleyuÀÖÓÚ£¬2005/1-2006/12£¬ÒѽáÌ⣬²ÎÓë
(28)¹ú¼ÒÖÐÒ½Ò©Àí¾Ö£¬02-03ZL46£¬ÖÐÒ©´ÙÄÚÔ´ÐÔ¿¹¾úëÄ×÷ÓÃleyuÀÖÓÚ£¬2003/01-2005/12£¬5ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(29)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬020772£¬¿¹¾úÖÐҩͨ¹ýTollÑùÊÜÌå¼Ò×å¶ÔÄÚÔ´ÐÔ¿¹¾úëĵÄÓ°Ï죬2003/01-2005/01£¬6ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(30)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬30271651£¬¿¹¾úÖÐҩͨ¹ýTollÑùÊÜÌå¼Ò×å¶ÔÄÚÔ´ÐÔ¿¹¾úëĵÄÓ°Ï죬2002/09-2005/12£¬18ÍòÔª£¬ÒѽáÌ⣬Ö÷³Ö
(31)¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð£¬30171201£¬×ÌÒõ²¹Éöµ÷ÕûÖ×Áö×Ôɱ»ùÒòÁÆ·¨Ñ×Ö¢ÃâÒß΢»·¾³×÷ÓÃleyuÀÖÓÚ£¬2002/01-2004/12£¬16ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(32)¹ú¼Ò¿Æ¼¼¹¥¹Ø¼Æ»®£¬2001BA701A25£¬ÖÐÒ½Ò©ÏÖ´ú»¯leyuÀÖÓںͲúÒµ»¯¿ª·¢£¬2001/11-2003/12£¬ÒѽáÌ⣬¹²Í¬Ö÷³Ö
(33)¹ã¶«Ê¡¿Æѧ¼¼ÊõÌü¿Æ¼¼¼Æ»®ÏîÄ¿£¬2002A301030207£¬´©ÐÄÁ«ÖƼÁµÄ¶þ´Î¿ª·¢leyuÀÖÓÚ£¬2001.11£¬ÒѽáÌ⣬²ÎÓë
(34)¹ã¶«Ê¡½ÌÓýÌü×ÔÈ»¿ÆѧleyuÀÖÓÚÏîÄ¿£¬ÎåÜßÉ¢Èí½ºÄÒÓÐЧÐÔÆÀ¼Û£¬2001/09-2003/12£¬ÒѽáÌ⣬²ÎÓë
(35)¹ã¶«Ê¡¿Æѧ¼¼ÊõÌü¿Æ¼¼¼Æ»®ÏîÄ¿£¬B60106£¬¹ã¶«Ê¡ÐÂҩɸѡÖصãʵÑéÊÒ£¬2001/07-2003/12£¬250ÍòÔª£¬ÒѽáÌ⣬²ÎÓë
(36)¹ã¶«Ê¡¿Æѧ¼¼ÊõÌü¿Æ¼¼¼Æ»®ÏîÄ¿£¬B01055£¬ÖÐÒ©²ÏÓ¼¿¹¾úëĵĿª·¢£¬2001/05£¬ÒѽáÌ⣬²ÎÓë
(37)31.leyuÀÖÓÚ¿ÆÑлù½ð£¬ÖÐÒ©´ÙÄÚÔ´ÐÔ¿¹¾úëÄ×÷ÓÃleyuÀÖÓÚ£¬2001/01-2003/12£¬ÒѽáÌ⣬Ö÷³Ö
(38)¹ã¶«Ê¡½ÌÓý¿Æѧ»ù½ð£¨¹ã¶«Ê¡½ÌÓýÌü×ÔÈ»¿ÆѧleyuÀÖÓÚÏîÄ¿£©£¬200013£¬»ùÒòоƬÔÚÖÐÒ©ÃâÒßÒ©ÀíleyuÀÖÓÚÖеÄÓ¦Óã¬2001/1-2002/12£¬ÒѽáÌ⣬Ö÷³Ö
(39)¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¿ÆÑлù½ð£¬ÖÐÒ©²ÄRAPD±ê×¼µÄ½¨Á¢£¬2000/09-2003/06£¬ÒѽáÌ⣬²ÎÓë
(40)¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö¿ÆÑпÎÌ⣬99530£¬±£ÐÄ¿µ¶ÔÐÄÁ¦Ë¥½ßÄ£ÐÍÐļ¡Ï¸°ûµòÍöµ÷¿Ø×÷ÓõÄleyuÀÖÓÚ£¬1999/10-2001/10£¬ÒѽáÌ⣬²ÎÓë
(41)¹ú¼ÒÖصã¿Æ¼¼ÏîÄ¿£¨¹¥¹Ø£©¼Æ»®£¬½¨Á¢¹ú¼ÒÐÂÒ©°²È«ÆÀ¼ÛleyuÀÖÓÚÖÐÐÄ£¬ÐÂÒ©leyuÀÖÓÚÓë²úÒµ¿ª·¢£¬1999/09-2000/12£¬ÒѽáÌ⣬²ÎÓë
(42)leyuÀÖÓÚ»ù½ðÏîÄ¿£¬C98021£¬ÐéÖ¤Tϸ°û¿¹ÔÊÜÌå»ùÒò±í´ïÌØÕ÷µÄleyuÀÖÓÚ£¬1999/01-2001/12£¬ÒѽáÌ⣬Ö÷³Ö
(43)¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö£¬98373£¬ÇàÌټÑ×»úÀí¡ªCOX-2Ñ¡ÔñÐÔÒÖÖÆ×÷ÓÃleyuÀÖÓÚ£¬1998/10-2001/10£¬ÒѽáÌ⣬Ö÷³Ö
(44)¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¿ÆÑлù½ð£¬97Z116£¬ÇàÌټÑ×»úÀí¡ªÑ¡ÔñÐÔ»·Ñõ»¯Ã¸ÒÖÖÆ×÷ÓõÄleyuÀÖÓÚ£¬1998/01-2001/12£¬ÒѽáÌ⣬²ÎÓë
(45)¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¡°¾ÅÎ塱¹ú¼ÒÅʵǼƻ®£¬º¬¿óÎïÒ©ÖÐÒ©ÖƼÁÖй¯¡¢ÉéµÄ×÷ÓÃÌصãºÍ°²È«ÐÔÆÀ¼ÛleyuÀÖÓÚ£¬1998/04£¬ÒѽáÌ⣬²ÎÓë
(46)¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¡°¾ÅÎ塱¹ú¼ÒÅʵǼƻ®£¬Ëľý×ÓÌÀÒæÆø½¡Æ¢Ò©Ð§µÄÎïÖÊ»ù´¡¼°Æä×÷ÓûúÀíleyuÀÖÓÚ£¬1998/04£¬ÒѽáÌ⣬²ÎÓë
(47)¹ã¶«Ê¡ÎÀÉúϵͳ¡°Îå¸öÒ»¿Æ½ÌÐËÒ½¹¤³Ì¡±£¬51-96-01£¬DNA¶à̬ÐÔ·ÖÎöÖÐÒ©¼ø±ðÖеÄÓ¦Óã¬1996-1998£¬ÒѽáÌ⣬²ÎÓë
(48)¹ã¶«Ê¡×ÔÈ»¿Æѧ»ù½ð£¬950615£¬ÖÐÒ©Ëæ»úÀ©Õ¹¶à̬ÐÔDNA£¨RAPD£©µÄleyuÀÖÓÚ£¬1995/09-1997/09£¬ÒѽáÌ⣬Ö÷³Ö
(49)¹ú¼ÒÖÐÒ½Ò©¹ÜÀí¾Ö¿ÆÑлù½ð£¬950379£¬Ëæ»úÒýÎïDNAÀ©Ôö¼°¶à̬ÐÔ·ÖÎöÔÚÖÐÒ©¼ø±ðÖеÄÓ¦Óã¬1995-1997£¬ÒѽáÌ⣬²ÎÓë
(50)ÎÀÉú²¿¿ÆѧleyuÀÖÓÚ»ù½ð£¬94-1-116£¬ÒýÖÖÎ÷Ñó²ÎÓë¼ÓÄôóÎ÷Ñó²ÎµÄDNAÖ¸ÎÆ£¨ÐòÁУ©¹¹½¨¼°±È½Ï£¬1994/10-1996/12£¬ÒѽáÌ⣬²ÎÓë
(51)¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö£¬91001£¬²¹Éö·½Ò©¶ÔÃâÒßÊÜÒÖ¶¯ÎïµÄÃâÒßµ÷½Ú×÷Óü°»úÀí̽ÌÖ£¬1991/06-1993/06£¬ÒѽáÌ⣬²ÎÓë
(52)¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö£¬90058£¬È˹¤ÓÕ·¢¶¯Îï¡°·¿À͹ý¶È¡±Ôì³ÉÉöÐéÄ£Ð͵ÄleyuÀÖÓÚ£¬1990/10-1992/10£¬ÒѽáÌ⣬²ÎÓë
(53)¹ã¶«Ê¡ÖÐÒ½Ò©¹ÜÀí¾Ö£¬90060£¬½ðØÑÉöÆøÍ裨ÌÀ£©¶ÔÉöÐ鶯ÎïµÄÃâÒß¡¢ÄÚ·ÖÃÚ×÷ÓõÄleyuÀÖÓÚ£¬1990/09-1992/09£¬ÒѽáÌ⣬²ÎÓë
´ú±íÐÔleyuÀÖÓÚÂÛÎÄ
1£©SCIÊÕ¼ÂÛÎÄ
[1] Li, Y. Y., Wang, X. J., Su, Y. L., Wang, Q., Huang, S. W., Pan, Z. F., Chen, Y. P., Liang, J. J., Zhang, M. L., Xie, X. Q., Wu, Z. Y., Chen, J. Y., Zhou, L*., & Luo, X*. (2021). Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s. Acta pharmacologica Sinica, 10.1038/s41401-021-00781-7. Advance online publication. £¨Í¨Ñ¶×÷Õߣ©
[2] Xu, B#., Huang, S#., Chen, Y., Wang, Q., Luo, S., Li, Y., Wang, X., Chen, J., Luo, X*., & Zhou, L*. (2021). Synergistic effect of combined treatment with baicalin and emodin on DSS-induced colitis in mouse. Phytotherapy research : PTR, 35(10), 5708¨C5719. £¨Í¨Ñ¶×÷Õߣ©
[3] Luo, X#., Wang, X#., Huang, S., Xu, B., Luo, S., Li, Y., Wang, Q., Chen, Y., Deng, X., Liu, L*., & Zhou, L*. (2021). Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway. International immunopharmacology, 90, 107224. £¨Í¨Ñ¶×÷Õߣ©
[4] Huang, S., He, J., Chen, Y., Wang, X., Li, Y., Su, Y., Wen, R., Li, X., Yang, G., Luo, S., Zhou, L*., & Luo, X*. (2022). Effect of Huangqin decoction on regulating intestinal flora in colitis mice characterized as inhibition of the NOD2-dependent pathway. Pharmaceutical biology, 60(1), 108¨C118. £¨Í¨Ñ¶×÷Õߣ©
[5] Fu YJ, Xu B, Huang SW, Luo X, Deng XL, Luo S, Liu C, Wang Q, Chen JY, Zhou L*, "Baicalin prevents LPS-induced activation of TLR4/NF-¦ÊB p65 pathway and inflammation in mice via inhibiting the expression of CD14." Acta Pharmacologica Sinica (2020) 0:1¨C9.£¨Í¨Ñ¶×÷Õߣ©
[6] Qi Liu#; Rui Zuo#; Kai Wang; Fei-fei Nong; Ya-jun Fu; Shao-wei Huang; Zeng-feng Pan; Yi Zhang; Xia Luo; Xiang-liang Deng; Xiao-xue Zhang; Lian Zhou*; Yang Chen."Oroxindin inhibits macrophage NLRP3 inflammasome activation in DSS-induced ulcerative colitis in mice via suppressing TXNIP-dependent NF-¦ÊB pathway." Acta Pharmacologica Sinica (2020) 0:1¨C11.£¨Í¨Ñ¶×÷Õߣ©
[7] Huang Shaowei; Fu Yajun; Xu Bo; Liu Chang; Wang Qing; Luo Shuang; Nong Feifei; Wang Xiaojing; Huang Songyu; Chen Jinyan; Zhou Lian*; Luo Xia, " Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway." Phytomedicine, 2020, 68: 153179.£¨Í¨Ñ¶×÷Õߣ©
[8] Feifei Nong, Shuang Luo, Yuqi Liang, Zhongxiang Zhao, Shangping Xing, Bin Wen, Lian Zhou*, "Evaluation of the effect of Dahuang¨CMudan decoction on TNBS-induced colitis using UPLC¨CQTOF/MS-based metabolomic analysis." Biomedical Chromatography.2020;e5003.£¨Í¨Ñ¶×÷Õߣ©
[9] Xia Luo, Bo Xu, Tianqin Xiong, Yulin Su, Chang liu, Yuanmei Ye,Mingming Ou and Lian Zhou,* "Hepatic dysfunction induced by intestinal dysbacteriosis mainly manifests as immunologic abnormity in mice." Pathogens and Disease,Pathogens and Disease, 2020, Vol. 78, No. 6.£¨Í¨Ñ¶×÷Õߣ©
[10] Xia Luo, Xiaojing Wang, Shaowei Huang, Bo Xu ,Shuang Luo, Yanyang Li, Qing Wang, Yanping Chen, Xiangliang Deng, Lingyun Liu ,Lian Zhou*, "Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway." International Immunopharmacology 90 (2021) 107224.£¨Í¨Ñ¶×÷Õߣ©
[11] Chang Liu, Yanyang Li, Yanping Chen, Shaowei Huang, Xiaojing Wang, Shuang Luo,Yulin Su, Lian Zhou* , and Xia Luo, "Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis." Hindawi Mediators of Inflammation Volume 2020, Article ID 5918587, 19 pagesShuang.£¨Í¨Ñ¶×÷Õߣ©
[12] Luo#; Ruyan Wen#; Qing Wang; Zhongxiang Zhao; Feifei Nong; Yajun Fu; Shaowei Huang; Jinyan Chen; Lian Zhou*; Xia Luo*. Rhubarb Peony Decoction Ameliorates Ulcerative Colitis in Mice by Regulating Gut Microbiota to Restoring Th17/Treg Balance. Journal of ethnopharmacology, 2019, 231:39-49.£¨Í¨Ñ¶×÷Õߣ©
[13] Jiang Y, Li X, Wu Y, Zhou L, Wang Z, Xiao W. Effect of Lentinan on Peyer's patch structure and function in an immunosuppressed mouse model. international journal of biological macromolecules. 2019 Sep 15;137:169-176. doi: 10.1016/j.ijbiomac.2019.06.206. Epub 2019 Jun 28.£¨Í¨Ñ¶×÷Õߣ©
[14] Deng X, Fu Y, Luo S, Luo X, Wang Q, Hu M3 Ma F, Ma CW, Zhou L. Polysaccharide from Radix Codonopsis has beneficial effects on the maintenance of T-cell balance in mice. Biomedicine & Pharmacotherapy.2019. Apr;112: 108682. doi: 10.1016/j.biopha.2019.108682. Epub 2019 Feb 20. £¨Í¨Ñ¶×÷Õߣ©
[15] Nong F#, Zhao Z#, Luo X, Liu C, Li H, Liu Q, Wen B, Zhou L*. Evaluation of the influence of Mirabilite on the absorption and pharmacokinetics of the ingredients in Dahuang-mudan decoction by a validated UPLC/ Q- TOF- MS/MS method. Biomed Chromatogr. 2019 Mar;33(3):e4423.£¨Í¨Ñ¶×÷Õߣ©
[16] Pan Z, Zhou Y, Luo X, Ruan Y*,Zhou L*, Wang Q, Yan YJ, Liu Q, Chen J. Against NF-¦ÊB/TSLP signal pathway, catechin alleviates the inflammation in allergic rhinitis. International Immunopharmacology. 2018 Aug;61:241-248.£¨Í¨Ñ¶×÷Õߣ©
[17] Luo X#, Pan Z#, Luo S, Liu Q, Huang S, Yang G, Nong F, Fu Y, Deng X, Zhou L*. Effects of ceftriaxone induced intestinal dysbacteriosis on regulatory T cells validated by anaphylactic mice. [J]. International Immunopharmacology. 2018 Jul, 5(60):221-227.£¨Í¨Ñ¶×÷Õߣ©
[18] Xia Luo, Shaowei Huang, Shuang Luo, Haifeng Liao, Yuanyuan Wang, Xiangliang Deng, Fangli Ma, Chung Wah Ma, Lian Zhou*. Identification of genes underlying the enhancement of immunity by a formula of lentinan, pachymaran and tremelia polysaccharides in immunosuppressive mice. Scientific reports, 2018 Jul 4;8(1):10082. doi: 10.1038/s41598-018-28414-w.£¨Í¨Ñ¶×÷Õߣ©
[19] Shuang Luo, Xiangliang Deng, Qi Liu, Zengfeng Pan, Zhongxiang Zhao, Lian Zhou*, Xia Luo*. Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice[J]. International Immunopharmacology. 2018 Jun;59:269-275.£¨Í¨Ñ¶×÷Õߣ©
[20] Xiangliang Deng, Shuang Luo, Xia Luo, Minghua Hu, Fangli Ma, Yuanyuan Wang, Xiaoping Lai, and Lian Zhou*. Polysaccharides from Chinese herbal Lycium barbarum induced systemic and local immune responses in H22 tumor-bearing mice [J]. Journal of immunology research. 2018 Jun 3: 3431782.£¨Í¨Ñ¶×÷Õߣ©
[21] Xiangliang Deng, Qi Liu, Yajun Fu, Xia Luo, Minghua Hu, Fangli M, Qing Wang, Xiaoping Lai* and Lian Zhou*. Effects of Lycium barbarum polysaccharides with different molecular weights on function of RAW264.7 macrophages[J]. Food and Agricultural Immunology. 04 Apr 2018 ¡£29(1):808-820£¨Í¨Ñ¶×÷Õߣ©
[22] Xiangliang Deng, Shuang Luo, Xia Luo, Minghua Hu, Fangli Ma, Yuanyuan Wang, Lian Zhou*, and Rongrong Huang. Fraction From Lycium barbarum Polysaccharides Reduces Immunotoxicity and Enhances Antitumor Activity of Doxorubicin in Mice [J]. Integrative Cancer Therapies. 2018 Sep;17(3):860-866. doi: 10.1177/1534735417753544.£¨Í¨Ñ¶×÷Õߣ©
[23] Liang J, Chen S, Chen J, Lin J, Xiong Q, Yang Y, Yuan J, Zhou L, He L, Hou S, Li S, Huang S, Lai X. Therapeutic roles of polysaccharides from Dendrobium Officinaleon colitis and its underlying mechanisms. Carbohydrate Polymers. 2018 Apr 1;185:159-168. doi: 10.1016/j.carbpol.2018.01.013.
[24] Jian Liang, Shuxian Chen, Youdong Hu, Yiqi Yang, Jun Yuan, Yanfang Wu, Shijie Li, Jizhong Lin, Lian He, Shaozhen Hou, Lian Zhou?, Song Huang?. Protective roles and mechanisms of Dendrobium officinal polysaccharides on secondary liver injury in acute colitis[J]. International Journal of Biological Macromolecules. 2018 Feb;107(Pt B):2201-2210.£¨Í¨Ñ¶×÷Õߣ©
2£©ÖÐÎĺËÐÄÆÚ¿¯
[1]ÖÜÁª,ÀîÑãÑï,ÂÞϼ.·¼ÏãÌþÊÜÌåÔÚ³¦µÀð¤Ä¤ÃâÒßÖеŦÄÜÒÔ¼°ÖÐÒ©¸ÉÔ¤½øÕ¹[J/OL].ÖйúÖÐÎ÷Ò½½áºÏÔÓÖ¾: 1-7[2021-03-17]. http://kns.cnki.net/kcms/deta/ 11.2787.R.20210302.1132.022.html. 02.1132.022.html.
[2]ÍõС¾²£¬ÂÞϼ£¬ÕÔÖÒÕý£¬ÂÞˬ£¬³Â½òÑÒ£¬ÖÜÁª£¬¡°ÉÖÒ©ÜÕͨ¹ýÒÖÖÆ TLR5±í´ï¼° T ϸ°û»î»¯¼õÇáÆϾÛÌÇÁòËáÄÆÓÕµ¼µÄСÊóÀ£ÑñÐԽ᳦Ñ×£¬¡±Ï¸°ûÓë·Ö×ÓÃâÒßѧÔÓÖ¾ 2020£¬36( 8).£¨Í¨Ñ¶×÷Õߣ©
[3]ÖÜÁª£¬»ÆÉÜ࣬ÂÞϼ£¬ËÕÓêÁÕ.³¦µÀð¤Ä¤ÃâÒß½øչΪÖÐÒ©ÃâÒßleyuÀÖÓÚÌṩµÄ»úÓö[J]. ÖйúÃâÒßѧÔÓÖ¾£¬ 2019, 34(24):2945-2952
[4]Å©·Æ·Æ,ÂÞˬ,ÕÔÖÓÏé,ÂÞϼ,ÁÖÃú¾ü,Îıò,ÖÜÁª*£¬»ùÓÚUPLC/Q-TOF-MS¼¼ÊõµÄ´ó»Æĵµ¤ÌÀÖÎÁÆIBD´óÊóµÄѪÇå´úл×éѧleyuÀÖÓÚ£¬ÖÐÒ©ÐÂÒ©ÓëÁÙ´²Ò©Àí,2019,30(05):571-579.£¨Í¨Ñ¶×÷Õߣ©
[5]ÖÜÁª£¬ÂÞˬ£¬Å©·Æ·Æ£¬ÂÞϼ. ´ó»Æĵµ¤ÌÀÖÎÁÆÑ×Ö¢ÐÔ³¦²¡µÄ»úÖÆleyuÀÖÓÚ[A]. ÖйúÃâÒßѧ»á.µÚÊ®Èý½ìÈ«¹úÃâÒßѧѧÊõ´ó»á·Ö»á³¡½»Á÷±¨¸æ[C].ÖйúÃâÒßѧ»á:ÖйúÃâÒßѧ»á,2018:1.
[6]Áõçù,ÂÞϼ,ÂÞˬ,ºÎ½ðéÅ,µËÏòÁÁ,³ÂÑï,ÖÜÁª*.ÉÖÒ©ÜÕͨ¹ýÒÖÖÆNLRP3Ñ×֢СÌåÖÎÁÆÀ£ÑñÐԽ᳦Ñ×СÊóµÄleyuÀÖÓÚ[J].ÖÐÒ©ÐÂÒ©ÓëÁÙ´²Ò©Àí, 20180725, 29 (04):409-414.£¨Í¨Ñ¶×÷Õߣ©
[7]ÅËÔö·é£¬ÖÜÔ°£¬ÈîÑÒ£¬ÂÞϼ£¬ãÆÑǽܣ¬ÖÜÁª*.¶ù²èËØÒÖÖÆNF-¦ÊB-TSLPͨ·»º½â¹ýÃôÐÔÏø´Ð¡ÊóÑ×Ö¢·´Ó¦[J].ÖйúÒ©Àíѧͨ±¨, 20180115, 34 (02):207-212.£¨Í¨Ñ¶×÷Õߣ©
[8] »ÆÕñ»ª£¬µËÏòÁÁ£¬ÕÅ¿Ãô£¬ÀµÁøæ㬠ºúÃ÷»ª£¬Âí·½Àø£¬ÂÞϼ£¬ÖÜÁª*. èÛ轶àÌǶÔÃâÒßÒÖÖÆСÊóºìϸ°ûÃâÒß¹¦ÄܵÄÓ°Ïì[J].ÖйúÃâÒßѧÔÓÖ¾, 20180220,34(02):214-217.£¨Í¨Ñ¶×÷Õߣ©
